000 01611cam a2200337 a 4500
005 20250918004506.0
008 090326s2008 nyua b 001 0 eng
020 _a9780849377846 (hardcover : alk. paper)
_cRM647.45
020 _a0849377846 (hardcover : alk. paper)
039 9 _a200906191636
_bmustaffa
_c200906191603
_dmustaffa
_c200904201151
_dmustaffa
_y03-26-2009
_zrazalis
040 _aUKM
060 _aQV38
_b.G3255 2008 9
090 _aQV38.G3255 2008 9
245 0 0 _aGeneric drug product development :
_bbioequivalence issues /
_c[edited by]Isadore Kanfer, Leon Shargel
260 _aNew York :
_bInforma Healthcare,
_c2008
300 _ax, 264 p. :
_bill. ;
_c24 cm.
504 _aIncludes bibliographical references and index
505 0 _aIntroduction-- bioequivalence issues / Isadore Kanfer and Leon Shargel -- Approved drug products with therapeutic equivalence evaluations (the orange book) / Loren Gelber -- Pharmaceutical alternatives : considerations for generic substitution / Roderick B. Walker, Roger K. Verbeeck, Isadore Kanfer -- Pharmacodynamic measurements for determination of bioequivalence / Manish Issar, Jeffrey G. Stark, and Leon Shargel --
650 2 _aDrugs, Generic
650 2 _aBiological availability
650 2 _aTherapeutic Equivalency
700 1 _aKanfer, Isadore
700 1 _aShargel, Leon,
_d1941-
907 _a.b1444625x
_b2019-11-12
_c2019-11-12
942 _c01
_n0
_kQV38.G3255 2008 9
914 _avtls003403894
990 _amk
991 _aJabatan Farmasi, KKL
998 _ad
_b2009-01-03
_cm
_da
_feng
_gnyu
_y0
_z.b1444625x
999 _c437157
_d437157